Skip to main content

Table 2 Morbidity and mortality

From: Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have an influence on the long-term prognosis?

   transhiatal (TH) transthoracic (TT) p-value
duration of surgery median (range) 254 (160–485)   335 (240–540)   <0.0005
(min)         U-test
blood loss median (range) 800 (0–7500)   1000 (200–5000)   0.002
(ml) intraoperatively         U-test
blood substitution median (range) 0 (0–6)   1 (0–14)   0.128
(PRBC) intraoperatively         U-test
surgical complications 44 103 42.7% 7 47 14.9% 0.001
         Fisher
general complications 22 102 21.6% 20 47 42.6% 0.011
         Fisher
total complications 62 103 60.2% 25 47 53.2% 0.477
         Fisher
duration of postoperative intensive care unit stay        
(days) median (range) 8 (2–107) 8 (1–97) 0.566
         U-test
duration of postoperative in-hospital stay        
(days) median (range) 21 (14–126) 20 (13–107) 0.646
hospital mortality   3 103 2.9% 7 47 14.9% 0.011
         Fisher
30-day mortality 2 100 2.0% 7 47 14.9% 0.005
         Fisher